We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+13.69%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$53.1B
AUM Growth
+$6.76B
(+15%)
Cap. Flow
+$2.33B
Cap. Flow
% of AUM
4.39%
Top 10 Holdings %
Top 10 Hldgs %
14.65%
Holding
2,220
New
169
Increased
729
Reduced
1,033
Closed
165
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zscaler
ZS
|
+$222M |
| 2 |
Palantir
PLTR
|
+$221M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$213M |
| 4 |
FirstEnergy
FE
|
+$189M |
| 5 |
Broadcom
AVGO
|
+$174M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$383M |
| 2 |
Philip Morris
PM
|
+$280M |
| 3 |
Entergy
ETR
|
+$207M |
| 4 |
Paychex
PAYX
|
+$206M |
| 5 |
Gilead Sciences
GILD
|
+$201M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.81% |
| 2 | Healthcare | 14.57% |
| 3 | Financials | 13.43% |
| 4 | Industrials | 10.29% |
| 5 | Consumer Discretionary | 9.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
651
Rocket Lab Corp
RKLB
$43.2B
| $6.86M | 0.01% |
+191,774
| New | +$4.69M |
|
652
Cinemark Holdings
CNK
$4.24B
| $6.84M | 0.01% |
226,668
-455,538
| -67% | -$13.8M |
|
653
Otis Worldwide
OTIS
$27.2B
| $6.81M | 0.01% |
68,797
-53,626
| -44% | -$5.18M |
|
654
Dover
DOV
$27.2B
| $6.76M | 0.01% |
36,901
-6
| -0% | -$1.04K |
|
655
QCR Holdings
QCRH
$1.65B
| $6.71M | 0.01% |
98,828
| – | – |
|
656
Dentsply Sirona
XRAY
$2.2B
| $6.69M | 0.01% |
421,556
+186,952
| +80% | +$2.8M |
|
657
MaxLinear
MXL
$5.75B
| $6.68M | 0.01% |
469,807
+332,932
| +243% | +$3.84M |
|
658
Fluence Energy
FLNC
$1.64B
| $6.67M | 0.01% |
994,064
+452,896
| +84% | +$2.16M |
|
|
KMTS
659
Kestra Medical Technologies
KMTS
$1.51B
| $6.63M | 0.01% |
400,000
| – | – |
|
660
Kirby Corp
KEX
$7.38B
| $6.53M | 0.01% |
57,617
-5,519
| -9% | -$579K |
|
661
CME Group
CME
$101B
| $6.5M | 0.01% |
23,572
+21,918
| +1,325% | +$5.96M |
|
662
Accenture
ACN
$115B
| $6.42M | 0.01% |
21,464
-12,564
| -37% | -$3.83M |
|
|
GTM
663
ZoomInfo Technologies
GTM
$1.19B
| $6.39M | 0.01% |
631,570
-383,557
| -38% | -$3.55M |
|
664
Teleflex
TFX
$5.84B
| $6.37M | 0.01% |
53,781
+1,353
| +3% | +$171K |
|
|
ONTF
665
DELISTED
ON24
ONTF
| $6.37M | 0.01% |
1,172,241
+4,578
| +0.4% | +$23.5K |
|
666
Tanger
SKT
$4.33B
| $6.35M | 0.01% |
207,627
+12,365
| +6% | +$379K |
|
|
CRCL
667
Circle Internet Group
CRCL
$23.9B
| $6.35M | 0.01% |
+35,000
| New | +$5.7M |
|
668
HCI Group
HCI
$2.32B
| $6.3M | 0.01% |
41,368
-71
| -0.2% | -$10.9K |
|
669
Mitsubishi UFJ Financial
MUFG
$253B
| $6.22M | 0.01% |
453,416
-173,667
| -28% | -$2.25M |
|
670
4D Molecular Therapeutics
FDMT
$824M
| $6.19M | 0.01% |
1,667,338
+417,157
| +33% | +$1.47M |
|
671
Pinnacle Financial Partners Inc
PNFP
$15.3B
| $6.18M | 0.01% |
55,976
-71
| -0.1% | -$7.33K |
|
672
Western Union
WU
$2.25B
| $6.17M | 0.01% |
732,676
+314,030
| +75% | +$2.98M |
|
673
SunCoke Energy
SXC
$873M
| $6.16M | 0.01% |
716,633
-120,942
| -14% | -$1.05M |
|
674
BrightView Holdings
BV
$1.03B
| $6.15M | 0.01% |
369,413
+3,044
| +0.8% | +$45.5K |
|
675
Capri Holdings
CPRI
$1.5B
| $6.15M | 0.01% |
347,206
+325,241
| +1,481% | +$5.36M |
|
Similar funds
Federated Hermes's Q2 2025 Portfolio in Review
As of Q2 2025, Federated Hermes held 2,220 positions worth $53.1B, up 15% from $46.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Federated Hermes deployed $2.33B of net new capital in Q2 2025, opening 169 new positions and adding to 729 existing holdings. Its largest new stake was Genuine Parts: 882,160 shares worth $107M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $383M trimmed.
- Federated Hermes's largest Q2 2025 buy was Genuine Parts: 882,160 shares worth $107M.
- Federated Hermes added most to Zscaler in Q2 2025, an estimated $222M increase.
- Federated Hermes's biggest Q2 2025 reduction was Bristol-Myers Squibb, cutting an estimated $383M.
- Federated Hermes fully exited Regulus Therapeutics in Q2 2025, selling an estimated $39.2M.
- Federated Hermes's ten largest holdings make up 15% of its $53.1B portfolio in Q2 2025.
- Federated Hermes opened 169 new positions and closed 165 in Q2 2025.
- Federated Hermes's portfolio value rose 15% quarter-over-quarter to $53.1B.
Based on Federated Hermes's 13F filing for Q2 2025, filed 13 Aug 2025.